Michael A. Prudencio-Brunello
Papers
1
Total Citations
13
H-Index
1
About
Dr. Michael A. Prudencio-Brunello is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His major contributions lie in comparative effectiveness research, systematically evaluating modern surgical techniques to guide clinical decision-making. His landmark 2024 systematic review and meta-analysis, which directly compared holmium laser enucleation of the prostate (HoLEP) with robotic-assisted simple prostatectomy (RASP), has already garnered 13 citations, reflecting its immediate impact on the field. This work provides critical evidence on efficacy, safety, and efficiency trade-offs between these two advanced procedures, helping surgeons tailor interventions to patient needs. Dr. Prudencio-Brunello’s research is distinguished by its rigorous methodology and focus on optimizing outcomes in an aging population with rising BPH prevalence. His analyses are essential reading for urology residents and practicing surgeons seeking to navigate the evolving landscape of surgical BPH management. Through his scholarship, he is shaping the future of prostate surgery, emphasizing evidence-based practice and patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1